The C-type lectin DC-SIGN expressed on immature dendritic cells is a promising target for antiviral drug development. Previously, we have demonstrated that mono- and divalent C-glycosides based on d-manno and l-fuco configurations are promising DC-SIGN ligands. Here, we described the convergent synthesis of C-glycoside dendrimers decorated with 4, 6, 9, and 12 α-l-fucopyranosyl units and with 9 and 12 α-d-mannopyranosyl units. Their affinity against DC-SIGN was assessed by surface plasmon resonance (SPR) assays. For comparison, parent O-glycosidic dendrimers were synthesized and tested, as well. A clear increase of both affinity and multivalency effect was observed for C-glycomimetics of both types (mannose and fucose). However, when dodecavalent C-glycosidic dendrimers were compared, there was no difference in affinity regarding the sugar unit (l-fuco, IC50 17 μM; d-manno, IC50 12 μM). For the rest of glycodendrimers with l-fucose or d-mannose attached by the O- or C-glycosidic linkage, C-glycosidic dendrimers were significantly more active. These results show that in addition to the expected physiological stability, the biological activity of C-glycoside mimetics is higher in comparison to the corresponding O-glycosides and therefore these glycomimetic multivalent systems represent potentially promising candidates for targeting DC-SIGN.

Department of Chemistry of Natural Compounds University of Chemistry and Technology Prague Technická 5 166 28 Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc18025068

003      

CZ-PrNML

005      

20180718104218.0

007      

ta

008      

180709s2017 enk f 000 0|eng||

009      

AR

024    7_

$a 10.1039/c7ob00322f $2 doi

035    __

$a (PubMed)28443908

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a enk

100    1_

$a Bertolotti, Benedetta $u Department of Chemistry of Natural Compounds, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague, Czech Republic. Jitka.Moravcova@vscht.cz.

245    10

$a Polyvalent C-glycomimetics based on l-fucose or d-mannose as potent DC-SIGN antagonists / $c B. Bertolotti, I. Sutkeviciute, M. Ambrosini, R. Ribeiro-Viana, J. Rojo, F. Fieschi, H. Dvořáková, M. Kašáková, K. Parkan, M. Hlaváčková, K. Nováková, J. Moravcová,

520    9_

$a The C-type lectin DC-SIGN expressed on immature dendritic cells is a promising target for antiviral drug development. Previously, we have demonstrated that mono- and divalent C-glycosides based on d-manno and l-fuco configurations are promising DC-SIGN ligands. Here, we described the convergent synthesis of C-glycoside dendrimers decorated with 4, 6, 9, and 12 α-l-fucopyranosyl units and with 9 and 12 α-d-mannopyranosyl units. Their affinity against DC-SIGN was assessed by surface plasmon resonance (SPR) assays. For comparison, parent O-glycosidic dendrimers were synthesized and tested, as well. A clear increase of both affinity and multivalency effect was observed for C-glycomimetics of both types (mannose and fucose). However, when dodecavalent C-glycosidic dendrimers were compared, there was no difference in affinity regarding the sugar unit (l-fuco, IC50 17 μM; d-manno, IC50 12 μM). For the rest of glycodendrimers with l-fucose or d-mannose attached by the O- or C-glycosidic linkage, C-glycosidic dendrimers were significantly more active. These results show that in addition to the expected physiological stability, the biological activity of C-glycoside mimetics is higher in comparison to the corresponding O-glycosides and therefore these glycomimetic multivalent systems represent potentially promising candidates for targeting DC-SIGN.

650    _2

$a biomimetické materiály $x chemie $x farmakologie $7 D040761

650    _2

$a molekuly buněčné adheze $x antagonisté a inhibitory $7 D015815

650    _2

$a fukosa $x chemie $7 D005643

650    _2

$a inhibiční koncentrace 50 $7 D020128

650    _2

$a lektiny typu C $x antagonisté a inhibitory $7 D037181

650    _2

$a mannosa $x chemie $7 D008358

650    _2

$a receptory buněčného povrchu $x antagonisté a inhibitory $7 D011956

655    _2

$a časopisecké články $7 D016428

700    1_

$a Sutkeviciute, Ieva

700    1_

$a Ambrosini, Martino

700    1_

$a Ribeiro-Viana, Renato

700    1_

$a Rojo, Javier

700    1_

$a Fieschi, Franck

700    1_

$a Dvořáková, Hana

700    1_

$a Kašáková, Martina

700    1_

$a Parkan, Kamil

700    1_

$a Hlaváčková, Martina

700    1_

$a Nováková, Kateřina

700    1_

$a Moravcová, Jitka

773    0_

$w MED00007088 $t Organic & biomolecular chemistry $x 1477-0539 $g Roč. 15, č. 18 (2017), s. 3995-4004

856    41

$u https://pubmed.ncbi.nlm.nih.gov/28443908 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20180709 $b ABA008

991    __

$a 20180718104519 $b ABA008

999    __

$a ok $b bmc $g 1317199 $s 1021989

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2017 $b 15 $c 18 $d 3995-4004 $i 1477-0539 $m Organic & biomolecular chemistry $n Org Biomol Chem $x MED00007088

LZP    __

$a Pubmed-20180709